Patent ID: 9694052
Date: 2017-07-04
CPC Classifications: A61K,A61P

Claim:
1. A method of treating infertility comprising administering human-derived recombinant follicle stimulating hormone (FSH) that includes α2,3- and α2,6-sialylation to a patient in need of such treatment, wherein 50% to 99% of the total sialylation of the FSH is α2,3-sialylation and 1% to 50% of the total sialylation of the FSH is α2,6-sial y lation, and wherein the FSH is administered at a daily dose of, or a dose equivalent to a daily dose of, 11 to 13 μg to the patient having a serum anti-Müllerian hormone (AMH) level of <15 pmol/L.